Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.21.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 11, 2021
Apr. 13, 2021
Jan. 19, 2021
Nov. 03, 2020
Aug. 14, 2020
Jun. 03, 2020
Feb. 15, 2021
Jan. 25, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2018
Jun. 08, 2021
Mar. 28, 2021
Jan. 29, 2021
Nov. 12, 2020
Sep. 30, 2018
Stockholders' Equity (Details) [Line Items]                                        
Preferred stock, authorized (in Shares)                 5,000,000     5,000,000   10,000,000            
Preferred stock, par value (in Dollars per share)                 $ 0.0001     $ 0.0001   $ 0.0001            
Preferred shares designated (in Shares)                 5,000,000     5,000,000                
Certificate of designation series A preferred stock (in Shares)         5,000,000                              
Conversion trigger, percentage                       25.00%                
Conversion trigger, per share (in Dollars per share)                       $ 6.00                
Effective interest rate                 25.00%     25.00%                
Effective conversion price                 $ 6.00     $ 6.00                
Common stock, authorized (in Shares)                 116,666,667     116,666,667   116,666,667            
Common stock, par value (in Dollars per share)                 $ 0.0001     $ 0.0001   $ 0.0001            
Common stock, shares issued (in Shares)                 34,038,707     34,038,707   34,038,707            
Aggregate of shares (in Shares)                                 8,142,894      
Shares issued (in Shares) 7,360,000                             6,400,000     116,666,667  
Purchase additional shares (in Shares)                               960,000        
Common stock public price (in Dollars per share) $ 6.51                                      
Public price (in Dollars per share) $ 7.00                                      
Underwriter expenses $ 47,523,583                                      
Reverse stock split, description       On November 3, 2020, the Board of Directors of the Company approved a one-for-three reverse stock split of the Company’s authorized and outstanding common stock, effective November 13, 2020 (the “Reverse Stock Split”).                                 
Capital value                                   $ 150,000,000    
Purchase aggregate description                       During the six months ended June 30, 2020, the Company’s Board issued (i) Warrants to purchase an aggregate of 279,460 shares of Common Stock with an exercise price of $7.50 per share and (ii) Warrants to purchase an aggregate of 9,793 shares of Common Stock with an exercise price of $6.39 per share.                
Number of warrants to purchase of common stock (in Shares)                 6,667 131,271   6,667                
Weighted-average contractual remaining life                       1 year 9 months 18 days                
Exercise price (in Dollars per share)   $ 8.72             $ 9.75 $ 9.75                    
Warrants value                 $ 65,003 $ 1,279,892   $ 65,003                
Common stock reserved for issuance (in Shares)   50,000                                    
Stock options to purchase of common stock (in Shares)                 643,006 593,006   643,006   568,006            
Stock options exercise price (in Dollars per share)                 $ 7.03 $ 7.63   $ 7.03   $ 7.39            
Fair value per share (in Dollars per share)   $ 2.64                                    
Stock compensation expense                 $ 190,357   $ 737,306                  
Share based compensation                       $ 287,519 $ 752,785              
Stock-based compensation                 0   $ 0                  
Compensation, description                       the Compensation Committee approved the following grants: (a) for Messrs. Cohen, Reisfield and Silverman (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (b) for Mr. Seidl and Ms. Sood (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (ii) 10,000 restricted stock units pursuant to the 2018 Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The 5,000 restricted stock units granted to each of Messrs. Cohen, Reisfield, Silverman and Seidl and Ms. Sood vest in four successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. The 10,000 restricted stock units granted to Mr. Seidl and Ms. Sood vest in eight successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. All restricted stock units granted to these directors shall vest in full immediately upon a change in control. The company recognized stock-based compensation of $111,300 and $222,600 for the three and six months ended June 30, 2021. As of June 30, 2021, the unrecognized compensation expense was $349,800.                
Stock Options [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Stock options to purchase of common stock (in Shares)             25,000 90,000                        
Stock-based compensation expense                           $ 514,866            
Options term             10 years 10 years                        
Stock options exercise price (in Dollars per share)             $ 12.92 $ 12.72                        
Weighted average grant-date fair value (in Dollars per share)             $ 5.82 $ 5.72                        
Unrecognized compensation expense                 224,000     $ 224,000                
Weighted-average contractual remaining life                       1 year 3 months 18 days                
Thomas Bushey [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Recognized stock based compensation                 0     $ 1,050,000                
Restricted Stock Units (RSUs) [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Weighted-average contractual remaining life                           1 year 3 months            
Weighted average grant-date fair value (in Dollars per share)                       $ 0.64                
Unrecognized compensation expense                           $ 5,250,000            
Stock compensation expense                           $ 3,150,000            
Restricted stock purchase (in Shares)           1,000,000                 126,160          
Weighted average grant-date fair value of exercise price (in Dollars per share)           $ 8.40                            
Vesting period           2 years           2 years                
Restricted Stock Units (RSUs) [Member] | Thomas Bushey [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Description of restricted stock units     Effective January 19, 2021, (i) Mr. Bushey received 500,000 RSU Shares (375,000 RSU Shares vested as of December 31, 2020 and 125,000 RSU Shares on which the Compensation Committee accelerated vesting), which RSU Shares will be issued on June 3, 2022 pursuant to Mr. Bushey’s deferral election, and (ii) 500,000 RSU shares were canceled.                                  
Consultant [Member] | Restricted Stock Units (RSUs) [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Stock compensation expense                       $ 0 $ 10,120              
Director [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Stock compensation expense                       270,000                
Recognized stock based compensation                 $ 0     $ 90,000                
Director [Member] | Restricted Stock Units (RSUs) [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Stock Issued During Period, Value, Restricted Stock Award, Forfeitures               $ 60,000                        
Series A Convertible Preferred Stock [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Preferred stock, authorized (in Shares)                 5,000,000     5,000,000   5,000,000            
Preferred stock, par value (in Dollars per share)                 $ 0.0001     $ 0.0001   $ 0.0001            
Preferred shares designated (in Shares)                 5,000,000     5,000,000                
2018 Equity Incentive Plan [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Common stock reserved for issuance (in Shares)                                       3,333,334
Preferred Stock [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Preferred stock, authorized (in Shares)                 10,000,000     10,000,000                
Preferred stock, par value (in Dollars per share)                 $ 0.0001     $ 0.0001                
Warrant [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Number of warrants to purchase of common stock (in Shares)                 1,741,865     1,741,865                
Warrants exercise price (in Dollars per share)                 $ 9.11     $ 9.11                
Warrant [Member] | Minimum [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Warrants exercise price (in Dollars per share)                 0.03     0.03                
Warrant [Member] | Maximum [Member]                                        
Stockholders' Equity (Details) [Line Items]                                        
Warrants exercise price (in Dollars per share)                 $ 9.75     $ 9.75